40510-86-9

Basic information

• Product Name: chloromethyl cyclohexyl carbonate
• Synonyms: chloromethyl cyclohexyl carbonate
• CAS NO: 40510-86-9
• Molecular Weight: 192.642
• Mol File: 40510-86-9.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: chloromethyl cyclohexyl carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: chloromethyl cyclohexyl carbonate(40510-86-9)
• EPA Substance Registry System: chloromethyl cyclohexyl carbonate(40510-86-9)

Safety Data

• Hazardous Substances Data: 40510-86-9(Hazardous Substances Data)

Upstream product

• 22128-62-7 carbonochloridic acid, chloromethyl ester 
• 108-93-0 cyclohexanol 

Downstream Products

• 873425-12-8 C₂₄H₃₆N₅O₁₀P 
• 873425-08-2 C₂₅H₃₈N₅O₁₀P 
• 1445563-89-2 (2R)-3-(1-amino-7-trifluoromethoxyisoquinolin-6-yl)-2-[(3S)-2-oxo-3-[(2-pyrrolidin-1-ylthiazole-5-sulfonyl)amino]pyrrolidin-1-yl]propionic acid cyclohexyloxycarbonyloxymethyl ester 
• 1427049-18-0 carbonic acid 7-[4-(4-benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinolin-1-ylmethyl ester cyclohexyl ester hydrochloride 
• 1427049-01-1 7-[4-(4-benzo[b]thiophene-4-yl-piperazin-1-yl)butoxy]quinolin-2-yloxymethyl cyclohexyl carbonate 
• 95789-55-2 cyclohexyloxycarbonyloxymethyl iodide 

Relevant articles and documents

Antiviral novel nucleoside reverse transcriptase inhibitors

The invention relates to compounds of antiviral novel nucleoside reverse transcriptase inhibitors, pharmaceutical compositions containing the compounds, and preparation and use of the compounds, and particularly discloses fused pyrimidine compounds shown in formula (I) and the pharmaceutical compositions containing the compounds, pharmaceutically acceptable salts, stereoisomers, solvates, hydrates, crystal forms, prodrugs or isotope derivatives. The compounds can be used for treating and/or preventing viral infectious diseases, such as human immunodeficiency virus (HIV) and hepatitis B virus (HBV). The formula (I) is shown in the specification.

Influenza virus replication inhibitors and uses thereof (by machine translation)

The invention provides a compound as an influenza virus replication inhibitor, a method for preparing the same, a pharmaceutical composition containing the compound and application. (by machine translation)

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).